These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 18708166)
21. [New diagnostic and evaluative tests for rheumatoid arthritis]. Hayashi N; Nishimura K; Morinobu A; Kumagai S Rinsho Byori; 2007 Apr; 55(4):388-96. PubMed ID: 17511271 [TBL] [Abstract][Full Text] [Related]
22. Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor. Yamane T; Hashiramoto A; Tanaka Y; Tsumiyama K; Miura Y; Shiozawa K; Chihara K; Shiozawa S J Rheumatol; 2008 Mar; 35(3):414-20. PubMed ID: 18203327 [TBL] [Abstract][Full Text] [Related]
23. [Antibodies to cyclic citrullinized peptide in rheumatoid arthritis]. Aleksandrova EN; Chemeris NA; Karateev DE; Novikov AA; Brodetskaia KA; Nasonov EL Ter Arkh; 2004; 76(12):64-8. PubMed ID: 15724930 [TBL] [Abstract][Full Text] [Related]
24. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis. Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028 [TBL] [Abstract][Full Text] [Related]
25. [Immunologic laboratory testing in clinical practice for rheumatoid arthritis]. Ota T Rinsho Byori; 2006 Aug; 54(8):861-8. PubMed ID: 16989407 [TBL] [Abstract][Full Text] [Related]
26. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis. Liu X; Jia R; Zhao J; Li Z J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936 [TBL] [Abstract][Full Text] [Related]
27. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872 [TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays. Vander Cruyssen B; Cantaert T; Nogueira L; Clavel C; De Rycke L; Dendoven A; Sebag M; Deforce D; Vincent C; Elewaut D; Serre G; De Keyser F Arthritis Res Ther; 2006; 8(4):R122. PubMed ID: 16859515 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic characteristics of a gelatin based Waaler-Rose assay (Serodia-RA) for the detection of rheumatoid factor. Spiritus T; Verschueren P; Westhovens R; Bossuyt X Ann Rheum Dis; 2004 Sep; 63(9):1169-71. PubMed ID: 15308531 [TBL] [Abstract][Full Text] [Related]
30. Profiling of rheumatoid arthritis associated autoantibodies. Conrad K; Roggenbuck D; Reinhold D; Dörner T Autoimmun Rev; 2010 Apr; 9(6):431-5. PubMed ID: 19932198 [TBL] [Abstract][Full Text] [Related]
31. Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis. van Venrooij WJ; van Beers JJ; Pruijn GJ Ann N Y Acad Sci; 2008 Nov; 1143():268-85. PubMed ID: 19076355 [TBL] [Abstract][Full Text] [Related]
32. [Early prediction of joint destruction in rheumatoid arthritis]. Eguchi K Clin Calcium; 2007 Apr; 17(4):517-25. PubMed ID: 17404480 [TBL] [Abstract][Full Text] [Related]
33. [Novel autoantibodies for the diagnosis of rheumatoid arthritis]. Steiner G; Smolen JS Z Rheumatol; 2002 Dec; 61(6):667-73. PubMed ID: 12491130 [TBL] [Abstract][Full Text] [Related]
34. Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis. Goëb V; Dieudé P; Daveau R; Thomas-L'otellier M; Jouen F; Hau F; Boumier P; Tron F; Gilbert D; Fardellone P; Cornélis F; Le Loët X; Vittecoq O Rheumatology (Oxford); 2008 Aug; 47(8):1208-12. PubMed ID: 18535030 [TBL] [Abstract][Full Text] [Related]
35. [Diagnostic performance of anti-cyclic citrullinated antibodies and IgM rheumatoid factor in rheumatoid arthritis]. Lemos A; Ramos MP; Furtado MJ; Carvalho C; Santos MJ; Silva JC; Ventura H Acta Reumatol Port; 2007; 32(4):345-9. PubMed ID: 18159201 [TBL] [Abstract][Full Text] [Related]
36. Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor. Vander Cruyssen B; Peene I; Cantaert T; Hoffman IE; De Rycke L; Veys EM; De Keyser F Autoimmun Rev; 2005 Sep; 4(7):468-74. PubMed ID: 16137613 [TBL] [Abstract][Full Text] [Related]
37. Diagnosing early-onset rheumatoid arthritis: the role of anti-CCP antibodies. Vasishta A Am Clin Lab; 2002; 21(7):34-6. PubMed ID: 12380030 [TBL] [Abstract][Full Text] [Related]
38. Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis. Mutlu N; Bicakcigil M; Tasan DA; Kaya A; Yavuz S; Ozden AI J Rheumatol; 2009 Mar; 36(3):491-500. PubMed ID: 19228660 [TBL] [Abstract][Full Text] [Related]
39. [Diagnostic and prognostic significance of antibodies against citrullinated peptides]. Schulze-Koops H; Manger B Dtsch Med Wochenschr; 2006 Feb; 131(6):269-71. PubMed ID: 16463231 [TBL] [Abstract][Full Text] [Related]
40. Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis and predictor of an erosive disease. Orbach H; Gilburd B; Brickman CM; Gerli R; Shoenfeld Y Isr Med Assoc J; 2002 Nov; 4(11 Suppl):892-3. PubMed ID: 12455175 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]